CLINICAL_TRIALS
research
· 2020-10-14
Clinical Trial Update: Cost- Effectiveness and Quality of Life Assessment in Major Depression Disorder [Phase 4]
Summary
Phase 4 trial evaluating cost-effectiveness and quality of life in major depressive disorder has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Federal University of Rio Grande do Sul | Conditions: Depression | Phase 4 | Status: COMPLETED | Results posted: 2020-10-14